Veradigm to acquire scienceio

Chicago--(business wire)-- #healthit--veradigm inc. (nasdaq: mdrx) (the “company”), a leading provider of healthcare data and technology products and solutions, today announced that it has signed a definitive agreement to acquire scienceio. the transaction has been unanimously approved by the veradigm board of directors and is expected to close as promptly as practicable following the satisfaction of customary closing conditions. founded in 2019, scienceio is a leading ai platform and foundation model prov.
MDRX Ratings Summary
MDRX Quant Ranking